Our aim was to investigate the relationship between NAFLD and impaired glucose metabolism in terms of insulin receptor substrate 1 and 2 (IRS1 and IRS2) expression in the liver. The gene discussed is IRS2; the disease is metabolic dysfunction-associated steatotic liver disease.